Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?

This publication has 38 references indexed in Scilit:

• Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.
  Journal of Clinical Investigation, 1998
• Cyclic AMP decreases the availability of 5-phosphortoosyl-1-pyrophosphate and decelerates de novo purine synthesis in rat hepatocytes
  Life Sciences, 1998
• Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides.
  Journal of Clinical Investigation, 1998
• Methotrexate in Rheumatoid Arthritis
  Drugs, 1994
• The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.
  Journal of Clinical Investigation, 1993
• The Salvage of Deoxycytidine into dCDP-Diacylglycerol by Macrophages and Lymphocytes
  Biochemical and Biophysical Research Communications, 1993
• Regulation of the mammalian carbamoyl‐phosphate synthetase II by effectors and phosphorylation
  European Journal of Biochemistry, 1992
• Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low‐dose methotrexate
  Arthritis & Rheumatism, 1989
• Inhibition of mannose incorporation into glycoproteins and dolichol-linked intermediates of sarcoma 180 cells by 6-methylmercaptopurine ribonucleoside
  International Journal of Cancer, 1987
• Polyglutamation of methotrexate. Is methotrexate a prodrug?
  Journal of Clinical Investigation, 1985